Krbkova L, Stanek G
J. G. Mendel Children's Hospital, Dept. of Infectious Diseases, Brno, Czech Republic.
Infection. 1996 Mar-Apr;24(2):170-3. doi: 10.1007/BF01713333.
A retrospective open study was conducted to determine the efficacy of penicillin and ceftriaxone in children with skin manifestations of Lyme borreliosis (solitary erythema migrans, multiple erythemata, borrelial lymphocytoma) and neuroborreliosis, respectively. One hundred sixty children were treated with penicillin and 41 with ceftriaxone for an average of 12 days. Serum antibodies to borreliae were determined before therapy and 2-3 and 4-6 weeks thereafter. At admission 44%/26%,8%/42%, and 40%/35% of erythema migrans, borrelial lymphocytoma and neuroborreliosis patients, respectively, were IgM/IgG positive. Four to 6 weeks after treatment the percentage of seropositives was 20%/15%,8%/61%, and 21%/44%, respectively. A 3 months follow-up was completed with 151 children. No child showed clinical evidence of illness, nor were there abnormalities in laboratory parameters.
进行了一项回顾性开放性研究,以分别确定青霉素和头孢曲松对莱姆病螺旋体病皮肤表现(单发游走性红斑、多发红斑、螺旋体淋巴细胞瘤)患儿和神经莱姆病患儿的疗效。160名儿童接受了青霉素治疗,41名儿童接受了头孢曲松治疗,平均治疗12天。在治疗前以及治疗后2 - 3周和4 - 6周测定血清抗螺旋体抗体。入院时,游走性红斑、螺旋体淋巴细胞瘤和神经莱姆病患者中分别有44%/26%、8%/42%和40%/35%的患者IgM/IgG呈阳性。治疗后4至6周,血清阳性的百分比分别为20%/15%、8%/61%和21%/44%。对151名儿童进行了3个月的随访。没有儿童出现疾病的临床证据,实验室参数也没有异常。